News Image

Investors should take note of NASDAQ:EXEL, a growth stock that remains attractively priced.

By Mill Chart

Last update: Jan 27, 2025

Uncover the potential of EXELIXIS INC (NASDAQ:EXEL), a growth stock that our stock screener found to be reasonably priced. NASDAQ:EXEL is excelling in growth aspects, maintaining a healthy financial position, and still offers an attractive valuation. We'll examine each aspect in detail.


Affordable Growth stocks image

Growth Assessment of NASDAQ:EXEL

ChartMill employs its own Growth Rating system for all stocks. This score, ranging from 0 to 10, is derived by evaluating different growth factors, such as EPS and revenue growth, taking into account both past performance and future projections. NASDAQ:EXEL has earned a 7 for growth:

  • EXEL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 485.71%, which is quite impressive.
  • Looking at the last year, EXEL shows a quite strong growth in Revenue. The Revenue has grown by 17.31% in the last year.
  • Measured over the past years, EXEL shows a quite strong growth in Revenue. The Revenue has been growing by 16.47% on average per year.
  • Based on estimates for the next years, EXEL will show a very strong growth in Earnings Per Share. The EPS will grow by 43.78% on average per year.
  • The Revenue is expected to grow by 11.43% on average over the next years. This is quite good.
  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

A Closer Look at Valuation for NASDAQ:EXEL

ChartMill assigns a proprietary Valuation Rating to each stock. The score is computed by evaluating various valuation aspects, like price to earnings and free cash flow, both absolutely as relative to the market and industry. NASDAQ:EXEL was assigned a score of 8 for valuation:

  • 95.75% of the companies in the same industry are more expensive than EXEL, based on the Price/Earnings ratio.
  • EXEL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.58.
  • Based on the Price/Forward Earnings ratio, EXEL is valued cheaper than 95.04% of the companies in the same industry.
  • EXEL is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.47, which is the current average of the S&P500 Index.
  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXEL indicates a rather cheap valuation: EXEL is cheaper than 97.17% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, EXEL is valued cheaply inside the industry as 96.46% of the companies are valued more expensively.
  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • EXEL has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as EXEL's earnings are expected to grow with 52.33% in the coming years.

How do we evaluate the Health for NASDAQ:EXEL?

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:EXEL scores a 8 out of 10:

  • EXEL has an Altman-Z score of 9.91. This indicates that EXEL is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of EXEL (9.91) is better than 86.02% of its industry peers.
  • EXEL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • A Current Ratio of 3.93 indicates that EXEL has no problem at all paying its short term obligations.
  • EXEL has a Quick Ratio of 3.88. This indicates that EXEL is financially healthy and has no problem in meeting its short term obligations.

Evaluating Profitability: NASDAQ:EXEL

ChartMill utilizes a Profitability Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of profitability ratios and margins, both in absolute terms and in comparison to industry peers. NASDAQ:EXEL has earned a 8 out of 10:

  • The Return On Assets of EXEL (15.77%) is better than 98.05% of its industry peers.
  • EXEL's Return On Equity of 20.52% is amongst the best of the industry. EXEL outperforms 97.17% of its industry peers.
  • EXEL has a Return On Invested Capital of 18.78%. This is amongst the best in the industry. EXEL outperforms 97.70% of its industry peers.
  • The 3 year average ROIC (7.03%) for EXEL is below the current ROIC(18.78%), indicating increased profibility in the last year.
  • EXEL has a better Profit Margin (22.43%) than 97.35% of its industry peers.
  • EXEL's Operating Margin of 29.22% is amongst the best of the industry. EXEL outperforms 98.41% of its industry peers.
  • EXEL has a Gross Margin of 96.25%. This is amongst the best in the industry. EXEL outperforms 96.64% of its industry peers.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

Check the latest full fundamental report of EXEL for a complete fundamental analysis.

Keep in mind

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

EXELIXIS INC

NASDAQ:EXEL (6/6/2025, 8:00:02 PM)

After market: 43 -0.03 (-0.07%)

43.03

+0.66 (+1.56%)



Find more stocks in the Stock Screener

EXEL Latest News and Analysis

ChartMill News Image18 hours ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) – A High-Growth Momentum Stock with Strong Technical Setup

EXELIXIS INC (NASDAQ:EXEL) combines strong earnings momentum with a high technical rating, making it a standout for growth investors. The stock's breakout setup suggests potential upside.

ChartMill News Image4 days ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) – A Strong Growth Stock with Technical Breakout Potential

EXELIXIS INC (NASDAQ:EXEL) shows strong growth fundamentals and a bullish technical setup, making it a stock worth watching for investors seeking growth opportunities.

ChartMill News Image12 days ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) – A Strong Contender for Growth Investors

EXELIXIS INC (NASDAQ:EXEL) shows strong earnings growth, expanding margins, and solid cash flow, making it a standout for growth investors following Louis Navellier’s strategy.

ChartMill News Image16 days ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) – A Strong Growth Stock with Attractive Valuation

EXELIXIS INC (NASDAQ:EXEL) offers strong growth, solid profitability, and an attractive valuation, making it a compelling choice for investors seeking affordable growth stocks in the biotech sector.

ChartMill News Image18 days ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) – An Undervalued Biotech Stock with Strong Fundamentals

EXELIXIS INC (NASDAQ:EXEL) is an undervalued biotech stock with strong profitability, financial health, and growth potential, making it a candidate for value investors.

ChartMill News Image21 days ago - ChartmillEXELIXIS INC (NASDAQ:EXEL) – A Strong Contender in High Growth Momentum and Minervini’s Trend Template

EXELIXIS INC (NASDAQ:EXEL) meets Minervini’s Trend Template with strong technicals and high growth momentum, making it a standout in biotech. Review its full technical and fundamental strengths before considering an investment.

Follow ChartMill for more